Detect Heart Failure Earlier
Before ECG leaves patients behind.
Cardio-HART helps identify Heart Failure and valve-disease indicators directly at first patient presentation — using a simple ECG-like workflow enhanced with deeper cardiac insight.
Heart Failure Is Still Detected Too Late
Many Heart Failure patients begin with vague or non-specific symptoms such as fatigue, shortness of breath, exercise intolerance, or mild fluid retention.
In frontline care, ECG is often the first cardiac test performed. But ECG evaluates electrical activity only. It does not provide visibility into:
- Cardiac structure
- Ventricular dysfunction
- Valve abnormalities
- Disease severity
As a result, early-stage Heart Failure and valve disease may remain undetected until echocardiography becomes available later in the pathway.
ECG Shows Electrical Activity. Heart Failure Is More Than Electrical.
Cardio-HART upgrades standard ECG with additional cardiac bio-signal analysis associated with:
- Heart function
- Structural abnormalities
- Valve dysfunction
- Heart Failure patterns
The result is deeper cardiac insight within a familiar, non-invasive workflow. Performed similarly to ECG — but designed to support more informed cardiac assessment.
Earlier Insight Into Heart Failure and Valve Disease
Cardio-HART supports identification of:
- HFpEF
- HFmrEF
- HFrEF
Including cases where ECG may appear inconclusive or non-specific. The system also provides supportive information related to:
- Ventricular dysfunction
- Atrial enlargement
- Diastolic dysfunction
- Pulmonary hypertension
- Valve abnormalities
Helping clinicians better understand overall cardiac status earlier in the patient pathway.
Valve Disease Often Remains Hidden
Valve disease frequently coexists with Heart Failure and significantly impacts patient risk and referral urgency. Cardio-HART supports identification of indicators associated with:
- Aortic stenosis
- Mitral regurgitation
- Tricuspid insufficiency
- Pulmonary hypertension
Without requiring immediate access to echocardiography.
Built for the Real Clinical Workflow
Cardio-HART is performed similarly to a standard 12-lead ECG.
- No specialist operator required
- No imaging workflow
- No disruption to existing pathways
Just deeper cardiac information from a familiar frontline test.
When ECG Is Inconclusive, Clinical Decisions Become Harder
Cardio-HART can help support:
- Earlier escalation decisions
- Improved referral quality
- Prioritisation of urgent patients
- More efficient use of echo resources
- Additional confidence when ECG is inconclusive
Applicable across:
- Heart Failure clinics
- Emergency assessment
- Outpatient pathways
- Internal medicine
- Cardiology feeder networks
- Pre-operative assessment
From First Presentation to Smarter Referral Decisions
1. Perform ECG-like test
Quick, non-invasive workflow familiar to clinical staff.
2. Receive AI-assisted report
Immediate structured cardiac insight in minutes.
3. Support pathway decisions
Treat, monitor, prioritise, or refer with greater confidence.
Validated for Frontline Cardiac Assessment
93% Specificity
90% Sensitivity
91% PPV
99% NPV
Performance based on Cardio-HART validation data.
See Cardio-HART in Practice
Access the brochure or schedule a short meeting to see how Cardio-HART supports earlier Heart Failure detection and smarter referral decisions.